欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2004, Vol. 9 ›› Issue (2): 171-176.

• 研究原著 • 上一篇    下一篇

生长抑素增强胆囊癌细胞化疗敏感性的研究

李济宇, 全志伟, 张强1, 刘建文1   

  1. 上海第二医科大学附属新华医院普外科, 上海 200092;
    1华东理工大学鲁华生物技术研究所新药药理研究室, 上海 200237
  • 收稿日期:2003-08-10 修回日期:2003-09-22 出版日期:2004-02-26 发布日期:2020-11-16
  • 通讯作者: 刘建文,男, 博士, 教授, 硕士生导师, 主要从事抗肿瘤药物及生物活性物质的药理药效学研究。Tel:021-64252981 Fax:021-64250068 E-mail: liujian@ecust.edu.cn
  • 作者简介:李济宇, 男, 博士, 主治医师, 主要从事肝胆肿瘤综合治疗机制的临床和实验研究。Tel:021-65065615  E-mail: Leejiyu@sina.com

Study of somatostatin on enhancing chemosensitivity of carcinoma of gdllbladder cells in vitro

LI Ji-Yu, QUAN Zhi-Wei, ZHANG Qiang1, LIU Jian-Wen1   

  1. Department of General Surgery, Xinhua Hospital, Shanghai Second Medical University, Shanghai 200092, China;
    1Department of New Drug Pharmacology, Luhua Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, China
  • Received:2003-08-10 Revised:2003-09-22 Online:2004-02-26 Published:2020-11-16

摘要: 目的: 探讨在生长抑素预先作用下, 胆囊癌细胞化疗敏感性的变化。方法: 运用生长抑素预先作用于体外培养的人胆囊癌细胞株, 24 h 后加入梯度浓度的化疗药物阿霉素, 观察癌细胞的生长曲线, 并与单独使用化疗药物的癌细胞生长曲线相比较。结果: 阿霉素能够明显抑制胆囊癌细胞的生长, 其作用呈现效应-浓度依赖性(P<0.05) 。生长抑素能够诱导离体胆囊癌细胞生长停滞于DNA 合成期(S期) 。经生长抑素预处理后, 阿霉素对癌细胞生长的抑制效果较单独用药为佳(P<0.01) 。结论: 生长抑素可增强胆囊癌细胞对化疗药物阿霉素的敏感性。

关键词: 生长抑素, 阿霉素, 化疗敏感性, 胆囊癌

Abstract: AIM: To explore the change of chemosensitivity of carcinoma of gdllbladder cells after treated with somatostatin.METHODS: Twenty-four hours after somatostatin given, gradient concentrations of Adriamycin were added and growth curve of carcinoma of gdllbladder cells was investigated.The inhibitory effects of Adriamycin plus somatostatin and adriamycin alone were compared .RESULTS: Concentration-dependent inhibition of cell growth was shown in carcinoma of gdllbladder cells in adriamycin group (P<0.01).Somatostatin was found to induce carcinoma of gdllbladder cells growth arrest in DNA-Synthesis phrase, i.e., S phrase.After treated with somatostatin, inhibition of adriamycin was enhanced compared with that in adriamycin alone group (P<0.01).CONCLUSION: Somatostatin can enhance the chemosensitivity of carcinoma of gdllbladder cells treating with adriamycin.

Key words: somatostatin, adriamycin, chemosensitivity, carcinoma of gdllbladder cells

中图分类号: